Literature DB >> 20531010

hMLH1 promoter methylation and JC virus T antigen presence in the tumor tissue of colorectal cancer Israeli patients of different ethnic groups.

Yaron Niv1, Alex Vilkin, Baruch Brenner, Yulia Kendel, Sara Morgenstern, Zohar Levi.   

Abstract

BACKGROUND: Hypermethylation of tumor suppressor genes' promoter and JC virus infection may be etiologic factors in the development of colorectal cancer (CRC).
OBJECTIVES: To look at both JC virus T antigen and hMLH1 promoter methylation in CRC tissue in Israeli ethnic groups with different incidence of CRC.
METHODS: Twenty-four consecutive patients with sporadic CRC were included in the study. Genomic DNA was isolated from paraffin-embedded microdomains removed from five slides of 7 mum by deparaffinizing in multiple xylene washes. Isolated DNA was used as a template for PCR to amplify DNA sequences coding the amino terminus of JC virus T antigen. Methylation-specific PCR was performed on bisulfite-modified DNA templates from CRC tissue materials to study methylation status of hMLH1 promoter, using two sets of primers specific for amplification of methylated and unmethylated alleles.
RESULTS: hMLH1 promoter methylation was observed in five patients (20.8%) who were also positive for JC virus T antigen, with even distribution among the ethnic groups. JC virus T antigen DNA was found in cancer tissues of 20 of the 24 patients; 50, 90.9, and 100% of Asia-Africa-born Jews, Europe-America-born Jews, and Israeli Arabs, respectively (P = 0.036 between the first group to the other).
CONCLUSION: Evidence for higher JC virus infection was shown among Europe-America-born Jews and Israeli Arabs. hMLH1 promoter methylation was evenly distributed between different ethnic groups in Israel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531010     DOI: 10.1097/MEG.0b013e32832e9d2c

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Presence of JC virus DNA in the tumor tissue and normal mucosa of patients with sporadic colorectal cancer (CRC) or with positive family history and Bethesda criteria.

Authors:  Alex Vilkin; Ziv Ronen; Zohar Levi; Sara Morgenstern; Marisa Halpern; Yaron Niv
Journal:  Dig Dis Sci       Date:  2011-08-10       Impact factor: 3.199

2.  Immune response to JC virus T antigen in patients with and without colorectal neoplasia.

Authors:  Lindsay D Butcher; Melissa Garcia; Mildred Arnold; Hideki Ueno; Ajay Goel; C Richard Boland
Journal:  Gut Microbes       Date:  2014-07-09

3.  Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC).

Authors:  Alex Vilkin; Yaron Niv
Journal:  Clin Epigenetics       Date:  2010-11-24       Impact factor: 6.551

Review 4.  Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis.

Authors:  Luis Del Valle; Sergio Piña-Oviedo
Journal:  Front Oncol       Date:  2019-08-08       Impact factor: 6.244

5.  Prevalence of JC and BK viruses in Patients with Colorectal Cancer: A Systematic Review and Meta- Analysis.

Authors:  Hamid Reza Shoraka; Omid Abobakri; Ahmad Naghibzade Tahami; Hamid Reza Mollaei; Zohre Bagherinajad; Reza Malekpour Afshar; Armita Shahesmaeili
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

Review 6.  Viruses in colorectal cancer.

Authors:  Luigi Marongiu; Heike Allgayer
Journal:  Mol Oncol       Date:  2021-09-30       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.